OptiNose Inc. (OPTN) Financial Statements (2024 and earlier)

Company Profile

Business Address 1020 STONY HILL ROAD
YARDLEY, PA 19067
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments73,68494,244110,502144,156147,144201,011
Cash and cash equivalents73,68494,244110,502144,156147,144201,011
Receivables19,92633,93235,44923,39413,643242
Inventory, net of allowances, customer advances and progress billings8,0529,44311,8479,0423,4847,132
Inventory8,0529,44311,8479,0423,4847,132
Other current assets  2,8652,5814,0603,6142,183
Other undisclosed current assets3,671   1752,289
Total current assets:105,333140,484160,379180,652168,060212,857
Noncurrent Assets
Property, plant and equipment8157951,3472,0283,0523,884
Other noncurrent assets1,5812,9434,3456,1331,538248
Total noncurrent assets:2,3963,7385,6928,1614,5904,132
TOTAL ASSETS:107,729144,222166,071188,813172,650216,989
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities45,38648,18457,14150,06435,00425,537
Accounts payable3,8865,2918,0135,4893,6257,116
Accrued liabilities41,50042,89349,12844,57531,37918,421
Debt 130,227128,575    
Other liabilities9111,9712,0942,1081,135 
Contract with customer, liability160
Total current liabilities:176,524178,73059,23552,17236,13925,697
Noncurrent Liabilities
Long-term debt and lease obligation  126,418125,20274,92872,500
Long-term debt, excluding current maturities  126,418125,20274,53172,500
Liabilities, other than long-term debt1,2221,2512,190   
Other liabilities6116262,190   
Operating lease, liability 611625  397
Other undisclosed noncurrent liabilities16,58920,865 4,651 181
Total noncurrent liabilities:17,81122,116128,608129,85374,92872,681
Total liabilities:194,335200,846187,843182,025111,06798,378
Equity
Equity, attributable to parent(86,606)(56,624)(21,772)6,78861,583118,611
Common stock11211182534641
Additional paid in capital633,742628,242588,288534,585489,565436,554
Accumulated other comprehensive loss(84)(84)(81)(85)(48)(57)
Accumulated deficit(720,376)(684,893)(610,061)(527,765)(427,980)(317,927)
Total equity:(86,606)(56,624)(21,772)6,78861,583118,611
TOTAL LIABILITIES AND EQUITY:107,729144,222166,071188,813172,650216,989

Income Statement (P&L) ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues70,98776,27674,65249,11734,6317,065
Cost of revenue(8,633)(9,263)(9,451)(7,520)(5,294)(1,588)
Cost of goods and services sold(8,633)(9,263)(9,151)(7,520)(5,294)(1,588)
Gross profit:62,35467,01365,20141,59729,3375,477
Operating expenses(85,102)(122,909)(131,651)(128,816)(124,938)(105,717)
Operating loss:(22,748)(55,896)(66,450)(87,219)(95,601)(100,240)
Nonoperating income2,527513524422,3262,405
Investment income, nonoperating2,527513524262,3592,453
Interest and debt expense(19,528)(16,843)(15,973)(13,008)(16,778)(9,229)
Other undisclosed income from continuing operations before equity method investments, income taxes      406
Loss from continuing operations before equity method investments, income taxes:(39,749)(72,226)(82,371)(99,785)(110,053)(106,658)
Other undisclosed income (loss) from continuing operations before income taxes4,266(2,607)75   
Loss from continuing operations:(35,483)(74,833)(82,296)(99,785)(110,053)(106,658)
Loss before gain (loss) on sale of properties:(82,296)(99,785)(110,053)(106,658)
Net loss:(35,483)(74,833)(82,296)(99,785)(110,053)(106,658)
Other undisclosed net loss attributable to parent      
Net loss attributable to parent:(35,483)(74,833)(82,296)(99,785)(110,053)(106,658)
Undistributed earnings (loss) allocated to participating securities, basic      
Net loss available to common stockholders, diluted:(35,483)(74,833)(82,296)(99,785)(110,053)(106,658)

Comprehensive Income ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(35,483)(74,833)(82,296)(99,785)(110,053)(106,658)
Comprehensive loss:(35,483)(74,833)(82,296)(99,785)(110,053)(106,658)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent (3)4(37)954
Comprehensive loss, net of tax, attributable to parent:(35,483)(74,836)(82,292)(99,822)(110,044)(106,604)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: